ATE139119T1 - Modulierung der reaktion von adenylatcyclase - Google Patents

Modulierung der reaktion von adenylatcyclase

Info

Publication number: ATE139119T1
Authority: AT; Austria
Prior art keywords: silicic acid; modulation; adenylatcyclase; reaction; bone strength
Prior art date: 1988-12-27

Application number

AT90901474T

Other languages

English (en)

Inventor

Karl E Wiegand

Robert K Rude

Original Assignee

Ethyl Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-12-27

Filing date

1989-12-22

Publication date

1996-06-15

1989-12-22 Application filed by Ethyl Corp filed Critical Ethyl Corp

1996-06-15 Application granted granted Critical

1996-06-15 Publication of ATE139119T1 publication Critical patent/ATE139119T1/de

Links

RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 abstract 3
235000012239 silicon dioxide Nutrition 0.000 abstract 3
230000037118 bone strength Effects 0.000 abstract 2
230000000694 effects Effects 0.000 abstract 2
208000020084 Bone disease Diseases 0.000 abstract 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 abstract 1
229910052791 calcium Inorganic materials 0.000 abstract 1
239000011575 calcium Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940088597 hormone Drugs 0.000 abstract 1
239000005556 hormone Substances 0.000 abstract 1
230000000944 neurotransmitter response Effects 0.000 abstract 1
210000001519 tissue Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Microbiology (AREA)
Biotechnology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Enzymes And Modification Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Stabilization Of Oscillater, Synchronisation, Frequency Synthesizers (AREA)
Steroid Compounds (AREA)

AT90901474T 1988-12-27 1989-12-22 Modulierung der reaktion von adenylatcyclase ATE139119T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/290,307 US4954448A (en)	1988-12-27	1988-12-27	Modulation of adenylate cyclase response

Publications (1)

Publication Number	Publication Date
ATE139119T1 true ATE139119T1 (de)	1996-06-15

Family

ID=23115404

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90901474T ATE139119T1 (de)	1988-12-27	1989-12-22	Modulierung der reaktion von adenylatcyclase

Country Status (10)

Country	Link
US (1)	US4954448A (de)
EP (1)	EP0451203B1 (de)
JP (1)	JP2960962B2 (de)
KR (1)	KR0133729B1 (de)
AT (1)	ATE139119T1 (de)
AU (1)	AU630143B2 (de)
CA (1)	CA1336066C (de)
DE (1)	DE68926682T2 (de)
ES (1)	ES2090121T3 (de)
WO (1)	WO1990007574A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5183061A (en) *	1988-07-22	1993-02-02	Ethyl Corporation	Silicon compounds in bone treatment
US5122603A (en) *	1989-03-08	1992-06-16	The University Of Virginia Alumni Patents Foundation	Purified insulin mediators and purification process for same
DE69510694T2 (de) *	1994-12-21	1999-10-21	Zeneca Ltd., London	Verfahren zum pfropfen
GB0504657D0 (en) *	2005-03-05	2005-04-13	Psimedica Ltd	Compositions and methods of treatment
JP5557448B2 (ja) *	2006-09-21	2014-07-23	俊樹大黒	硬組織再生促進剤
US11490601B2 (en) *	2020-12-23	2022-11-08	X Development Llc	Self-calibrating ultrasonic removal of ectoparasites from fish

1988
- 1988-12-27 US US07/290,307 patent/US4954448A/en not_active Expired - Lifetime
1989
- 1989-09-29 CA CA000615052A patent/CA1336066C/en not_active Expired - Lifetime
- 1989-12-22 AU AU48373/90A patent/AU630143B2/en not_active Ceased
- 1989-12-22 WO PCT/US1989/005799 patent/WO1990007574A1/en not_active Ceased
- 1989-12-22 JP JP2501915A patent/JP2960962B2/ja not_active Expired - Fee Related
- 1989-12-22 KR KR1019900701888A patent/KR0133729B1/ko not_active Expired - Fee Related
- 1989-12-22 ES ES90901474T patent/ES2090121T3/es not_active Expired - Lifetime
- 1989-12-22 AT AT90901474T patent/ATE139119T1/de not_active IP Right Cessation
- 1989-12-22 DE DE68926682T patent/DE68926682T2/de not_active Expired - Fee Related
- 1989-12-22 EP EP90901474A patent/EP0451203B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0451203A4 (en)	1991-12-11
CA1336066C (en)	1995-06-27
JP2960962B2 (ja)	1999-10-12
KR910700337A (ko)	1991-03-14
AU630143B2 (en)	1992-10-22
EP0451203A1 (de)	1991-10-16
US4954448A (en)	1990-09-04
JPH04504653A (ja)	1992-08-20
KR0133729B1 (ko)	1998-04-21
DE68926682D1 (de)	1996-07-18
DE68926682T2 (de)	1996-11-28
AU4837390A (en)	1990-08-01
ES2090121T3 (es)	1996-10-16
WO1990007574A1 (en)	1990-07-12
EP0451203B1 (de)	1996-06-12

Similar Documents

Publication	Publication Date	Title
NO921454L (no)	1992-06-10	Fremgangsmaater og blandinger for heling av ben
IT8419266A1 (it)	1985-07-20	Dispositivo per generare calore in tessuti" del corpo umano e procedimento di cenerazione di calore, particolarmente per la cura di tumori
EP0441974A4 (en)	1992-04-22	Device for irradiating laser beams
DK0641223T3 (da)	2001-10-01	Bioterapeutiske celleovertrukne mikrosfærer
ATE97316T1 (de)	1993-12-15	Kosmetisches mittel und zusammensetzung zur behandlung der haut.
ES2038122T3 (es)	1993-07-16	Un procedimiento para la preparacion de una composicion veterinaria2.
ATE112684T1 (de)	1994-10-15	Verwendung von igf-ii zur behandlung von knochenkrankheiten.
ATE249819T1 (de)	2003-10-15	Präparate zur äusserlichen anwendung zur behandlung von dermatosen
GR3030032T3 (en)	1999-07-30	Human il-3 variants.
ES2188582T3 (es)	2003-07-01	El uso de ranitidina-citrato de bismuto en combinacion con claritromicina o claritromicina y tetraciclina en la fabricacion de un medicamento para tratar trastornos gastrointestinales.
FR2755965B1 (fr)	1998-12-18	Composes biaromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
DE68926682D1 (de)	1996-07-18	Modulierung der reaktion von adenylatcyclase
IL138290A0 (en)	2001-10-31	Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
MX9806188A (es)	1998-10-31	Derivados de acidos benzofurano-acrilicos y su utilizacion como moduladores de los receptores rxrs o rars.
ATE181668T1 (de)	1999-07-15	Verwendung von 5-ht4 rezeptorantagonisten zur behandlung von vorhof-fibrillation und zur vorbeugung von schlaganfall
EP0266993A3 (en)	1988-07-27	Method and therapeutic compositions for the treatment of bleeding disorders
ATE200617T1 (de)	2001-05-15	Pharmazeutische zusammensetzungen zur transdermalen verabreichung von melatonin und/oder seine analoge
ATE64300T1 (de)	1991-06-15	Wirkstoffe zur anwendung bei der behandlung von tumoren.
ES2110057T3 (es)	1998-02-01	Composicion medicinal que contiene tcf-ii.
ES2085199B1 (es)	1996-12-01	Un procedimiento para la preparacion de una formulacion depot.
ES2044534T3 (es)	1994-01-01	Un metodo para la preparacion de una composicion tromboliticamente activa.
ES2042724T3 (es)	1993-12-16	Una composicion terapeutica o profilactica.
DE3485282D1 (de)	1992-01-02	Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.
ATE127118T1 (de)	1995-09-15	2-alkyl-3-benzoylbenzofurane zur behandlung von herzarrhythmia.
DE59407576D1 (de)	1999-02-18	Verwendung von Etofibrat und pharmazeutische Zusammensetzungen, enthaltend Etofibrat, zur Behandlung der diabetischen Angio- und Retinopathie

Legal Events

Date	Code	Title	Description
1996-12-15	UEP	Publication of translation of european patent specification
2005-09-15	REN	Ceased due to non-payment of the annual fee